ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: E. I. du Pont de Nemours and Company (DD) Report Updated: Sep 14, 2014 | Print This Page

E. I. du Pont de Nemours and Company© quotemedia

Company Profile

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides hybrid corn and soybean seeds, and grains under the Pioneer brand name; and herbicides, fungicides, and insecticides. The company’s Electronics & Communications segment supplies materials and systems for photovoltaic products, consumer electronics, displays, and advanced printing. The Industrial Biosciences segment provides a range of enzymes. The Nutrition & Health segment offers cultures, emulsifiers, gums, natural sweeteners, and soy-based food ingredients. The Performance Chemicals segment offers fluorochemicals, fluoropolymers, specialty and industrial chemicals, and white pigments for various markets, such as plastics and coatings, textiles, mining, pulp and paper, water treatment, and healthcare. The Performance Coatings segment supplies high performance liquid and powder coatings for motor vehicle original equipment manufacturers (OEM); the motor vehicle after-market; and general industrial applications, such as such as coatings for heavy equipment, pipes and appliances, and electrical insulation. The Performance Materials segment provides engineering polymers, packaging and industrial polymers, elastomers, films, parts, and systems and solutions for the automotive OEM and associated after-market industries, as well as electrical, electronics, packaging, construction, oil, photovoltaics, aerospace, chemical processing, and consumer durable goods. The Safety & Protection segment primarily offers nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The Pharmaceuticals segment represents its interest in the collaboration relating to Cozaar/Hyzaar antihypertensive drugs. The company was founded in 1802 and is headquartered in Wilmington, Delaware.

Recent News: E. I. du Pont de Nemours and Company